Evolus, Inc. (EOLS) stock
EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.07+0.38 (+5.68%)
Close on Nov 18, 2026Market cap $466.98MP/E –Yield –
Evolus market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Evolus's market cap was $489.82M on Nov 11, 2026, against $463.73M a year earlier. Over the last 5 years it ranged from $267.18M to $1.03B, with a median of $540.67M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $489.82M | +13.7% |
| 2025 | Dec 31, 2025 | $430.70M | -38.3% |
| 2024 | Dec 31, 2024 | $698.29M | +16.2% |
| 2023 | Dec 29, 2023 | $601.18M | +42.5% |
| 2022 | Dec 30, 2022 | $421.94M | +16.7% |
| 2021 | Dec 31, 2021 | $361.66M | +218.9% |
| 2020 | Dec 31, 2020 | $113.40M | -66.0% |
| 2019 | Dec 31, 2019 | $333.77M | +2.8% |
| 2018 | Dec 31, 2018 | $324.57M | – |
See a number that looks wrong?